N-[5-(anilinomethyl)-1-(3-methoxypropyl)benzimidazol-2-yl]-1,2-oxazole-5-carboxamide;4-cyano-N-[5-[[cyclohexyl(methyl)amino]methyl]-1-(3-imidazol-1-ylpropyl)benzimidazol-2-yl]benzamide;4-cyano-N-[5-[[cyclopentylmethyl(methyl)amino]methyl]-1-(3-methoxypropyl)benzimidazol-2-yl]benzamide;N-[5-[(cyclohexylamino)methyl]-1-(3-methoxypropyl)benzimidazol-2-yl]-1,2-oxazole-5-carboxamide;N-[5-[[cyclohexyl(methyl)amino]methyl]-1-(3-imidazol-1-ylpropyl)benzimidazol-2-yl]-1,2-oxazole-5-carboxamide;N-[5-[[cyclohexyl(methyl)amino]methyl]-1-(3-methoxypropyl)benzimidazol-2-yl]-1,2-oxazole-5-carboxamide

C148H180N34O14 — CID 158848842

IUPACN-[5-(anilinomethyl)-1-(3-methoxypropyl)benzimidazol-2-yl]-1,2-oxazole-5-carboxamide;4-cyano-N-[5-[[cyclohexyl(methyl)amino]methyl]-1-(3-imidazol-1-ylpropyl)benzimidazol-2-yl]benzamide;4-cyano-N-[5-[[cyclopentylmethyl(methyl)amino]methyl]-1-(3-methoxypropyl)benzimidazol-2-yl]benzamide;N-[5-[(cyclohexylamino)methyl]-1-(3-methoxypropyl)benzimidazol-2-yl]-1,2-oxazole-5-carboxamide;N-[5-[[cyclohexyl(methyl)amino]methyl]-1-(3-imidazol-1-ylpropyl)benzimidazol-2-yl]-1,2-oxazole-5-carboxamide;N-[5-[[cyclohexyl(methyl)amino]methyl]-1-(3-methoxypropyl)benzimidazol-2-yl]-1,2-oxazole-5-carboxamide
SMILESCN(Cc1ccc2c(c1)nc(NC(=O)c1ccc(C#N)cc1)n2CCCn1ccnc1)C1CCCCC1.CN(Cc1ccc2c(c1)nc(NC(=O)c1ccno1)n2CCCn1ccnc1)C1CCCCC1.COCCCn1c(NC(=O)c2ccc(C#N)cc2)nc2cc(CN(C)CC3CCCC3)ccc21.COCCCn1c(NC(=O)c2ccno2)nc2cc(CN(C)C3CCCCC3)ccc21.COCCCn1c(NC(=O)c2ccno2)nc2cc(CNC3CCCCC3)ccc21.COCCCn1c(NC(=O)c2ccno2)nc2cc(CNc3ccccc3)ccc21
InChIInChI=1S/C29H33N7O.C27H33N5O2.C25H31N7O2.C23H31N5O3.C22H29N5O3.C22H23N5O3/c1-34(25-6-3-2-4-7-25)20-23-10-13-27-26(18-23)32-29(36(27)16-5-15-35-17-14-31-21-35)33-28(37)24-11-8-22(19-30)9-12-24;1-31(18-21-6-3-4-7-21)19-22-10-13-25-24(16-22)29-27(32(25)14-5-15-34-2)30-26(33)23-11-8-20(17-28)9-12-23;1-30(20-6-3-2-4-7-20)17-19-8-9-22-21(16-19)28-25(29-24(33)23-10-11-27-34-23)32(22)14-5-13-31-15-12-26-18-31;1-27(18-7-4-3-5-8-18)16-17-9-10-20-19(15-17)25-23(28(20)13-6-14-30-2)26-22(29)21-11-12-24-31-21;2*1-29-13-5-12-27-19-9-8-16(15-23-17-6-3-2-4-7-17)14-18(19)25-22(27)26-21(28)20-10-11-24-30-20/h8-14,17-18,21,25H,2-7,15-16,20H2,1H3,(H,32,33,37);8-13,16,21H,3-7,14-15,18-19H2,1-2H3,(H,29,30,33);8-12,15-16,18,20H,2-7,13-14,17H2,1H3,(H,28,29,33);9-12,15,18H,3-8,13-14,16H2,1-2H3,(H,25,26,29);8-11,14,17,23H,2-7,12-13,15H2,1H3,(H,25,26,28);2-4,6-11,14,23H,5,12-13,15H2,1H3,(H,25,26,28)
InChIKeyIZEKAXPSXPAAIT-UHFFFAOYSA-N
MW2659.29 g/mol
LogP26.10
Rot. Bonds55

About N-[5-(anilinomethyl)-1-(3-methoxypropyl)benzimidazol-2-yl]-1,2-oxazole-5-carboxamide;4-cyano-N-[5-[[cyclohexyl(methyl)amino]methyl]-1-(3-imidazol-1-ylpropyl)benzimidazol-2-yl]benzamide;4-cyano-N-[5-[[cyclopentylmethyl(methyl)amino]methyl]-1-(3-methoxypropyl)benzimidazol-2-yl]benzamide;N-[5-[(cyclohexylamino)methyl]-1-(3-methoxypropyl)benzimidazol-2-yl]-1,2-oxazole-5-carboxamide;N-[5-[[cyclohexyl(methyl)amino]methyl]-1-(3-imidazol-1-ylpropyl)benzimidazol-2-yl]-1,2-oxazole-5-carboxamide;N-[5-[[cyclohexyl(methyl)amino]methyl]-1-(3-methoxypropyl)benzimidazol-2-yl]-1,2-oxazole-5-carboxamide

N-[5-(anilinomethyl)-1-(3-methoxypropyl)benzimidazol-2-yl]-1,2-oxazole-5-carboxamide;4-cyano-N-[5-[[cyclohexyl(methyl)amino]methyl]-1-(3-imidazol-1-ylpropyl)benzimidazol-2-yl]benzamide;4-cyano-N-[5-[[cyclopentylmethyl(methyl)amino]methyl]-1-(3-methoxypropyl)benzimidazol-2-yl]benzamide;N-[5-[(cyclohexylamino)methyl]-1-(3-methoxypropyl)benzimidazol-2-yl]-1,2-oxazole-5-carboxamide;N-[5-[[cyclohexyl(methyl)amino]methyl]-1-(3-imidazol-1-ylpropyl)benzimidazol-2-yl]-1,2-oxazole-5-carboxamide;N-[5-[[cyclohexyl(methyl)amino]methyl]-1-(3-methoxypropyl)benzimidazol-2-yl]-1,2-oxazole-5-carboxamide (PubChem CID 158848842) has the molecular formula C148H180N34O14 and a molecular weight of 2659.29 g/mol. Its IUPAC name is N-[5-(anilinomethyl)-1-(3-methoxypropyl)benzimidazol-2-yl]-1,2-oxazole-5-carboxamide;4-cyano-N-[5-[[cyclohexyl(methyl)amino]methyl]-1-(3-imidazol-1-ylpropyl)benzimidazol-2-yl]benzamide;4-cyano-N-[5-[[cyclopentylmethyl(methyl)amino]methyl]-1-(3-methoxypropyl)benzimidazol-2-yl]benzamide;N-[5-[(cyclohexylamino)methyl]-1-(3-methoxypropyl)benzimidazol-2-yl]-1,2-oxazole-5-carboxamide;N-[5-[[cyclohexyl(methyl)amino]methyl]-1-(3-imidazol-1-ylpropyl)benzimidazol-2-yl]-1,2-oxazole-5-carboxamide;N-[5-[[cyclohexyl(methyl)amino]methyl]-1-(3-methoxypropyl)benzimidazol-2-yl]-1,2-oxazole-5-carboxamide.

Molecular Properties

Compound NameN-[5-(anilinomethyl)-1-(3-methoxypropyl)benzimidazol-2-yl]-1,2-oxazole-5-carboxamide;4-cyano-N-[5-[[cyclohexyl(methyl)amino]methyl]-1-(3-imidazol-1-ylpropyl)benzimidazol-2-yl]benzamide;4-cyano-N-[5-[[cyclopentylmethyl(methyl)amino]methyl]-1-(3-methoxypropyl)benzimidazol-2-yl]benzamide;N-[5-[(cyclohexylamino)methyl]-1-(3-methoxypropyl)benzimidazol-2-yl]-1,2-oxazole-5-carboxamide;N-[5-[[cyclohexyl(methyl)amino]methyl]-1-(3-imidazol-1-ylpropyl)benzimidazol-2-yl]-1,2-oxazole-5-carboxamide;N-[5-[[cyclohexyl(methyl)amino]methyl]-1-(3-methoxypropyl)benzimidazol-2-yl]-1,2-oxazole-5-carboxamide
PubChem CID158848842
Molecular FormulaC148H180N34O14
Molecular Weight2659.29 g/mol
Exact Mass2657.44
IUPAC NameN-[5-(anilinomethyl)-1-(3-methoxypropyl)benzimidazol-2-yl]-1,2-oxazole-5-carboxamide;4-cyano-N-[5-[[cyclohexyl(methyl)amino]methyl]-1-(3-imidazol-1-ylpropyl)benzimidazol-2-yl]benzamide;4-cyano-N-[5-[[cyclopentylmethyl(methyl)amino]methyl]-1-(3-methoxypropyl)benzimidazol-2-yl]benzamide;N-[5-[(cyclohexylamino)methyl]-1-(3-methoxypropyl)benzimidazol-2-yl]-1,2-oxazole-5-carboxamide;N-[5-[[cyclohexyl(methyl)amino]methyl]-1-(3-imidazol-1-ylpropyl)benzimidazol-2-yl]-1,2-oxazole-5-carboxamide;N-[5-[[cyclohexyl(methyl)amino]methyl]-1-(3-methoxypropyl)benzimidazol-2-yl]-1,2-oxazole-5-carboxamide
SMILESCN(Cc1ccc2c(c1)nc(NC(=O)c1ccc(C#N)cc1)n2CCCn1ccnc1)C1CCCCC1.CN(Cc1ccc2c(c1)nc(NC(=O)c1ccno1)n2CCCn1ccnc1)C1CCCCC1.COCCCn1c(NC(=O)c2ccc(C#N)cc2)nc2cc(CN(C)CC3CCCC3)ccc21.COCCCn1c(NC(=O)c2ccno2)nc2cc(CN(C)C3CCCCC3)ccc21.COCCCn1c(NC(=O)c2ccno2)nc2cc(CNC3CCCCC3)ccc21.COCCCn1c(NC(=O)c2ccno2)nc2cc(CNc3ccccc3)ccc21
InChIInChI=1S/C29H33N7O.C27H33N5O2.C25H31N7O2.C23H31N5O3.C22H29N5O3.C22H23N5O3/c1-34(25-6-3-2-4-7-25)20-23-10-13-27-26(18-23)32-29(36(27)16-5-15-35-17-14-31-21-35)33-28(37)24-11-8-22(19-30)9-12-24;1-31(18-21-6-3-4-7-21)19-22-10-13-25-24(16-22)29-27(32(25)14-5-15-34-2)30-26(33)23-11-8-20(17-28)9-12-23;1-30(20-6-3-2-4-7-20)17-19-8-9-22-21(16-19)28-25(29-24(33)23-10-11-27-34-23)32(22)14-5-13-31-15-12-26-18-31;1-27(18-7-4-3-5-8-18)16-17-9-10-20-19(15-17)25-23(28(20)13-6-14-30-2)26-22(29)21-11-12-24-31-21;2*1-29-13-5-12-27-19-9-8-16(15-23-17-6-3-2-4-7-17)14-18(19)25-22(27)26-21(28)20-10-11-24-30-20/h8-14,17-18,21,25H,2-7,15-16,20H2,1H3,(H,32,33,37);8-13,16,21H,3-7,14-15,18-19H2,1-2H3,(H,29,30,33);8-12,15-16,18,20H,2-7,13-14,17H2,1H3,(H,28,29,33);9-12,15,18H,3-8,13-14,16H2,1-2H3,(H,25,26,29);8-11,14,17,23H,2-7,12-13,15H2,1H3,(H,25,26,28);2-4,6-11,14,23H,5,12-13,15H2,1H3,(H,25,26,28)
InChIKeyIZEKAXPSXPAAIT-UHFFFAOYSA-N
XLogP26.10
TPSA542.80 Ų
H-Bond Donors8
H-Bond Acceptors42
Rotatable Bonds55
Heavy Atoms196
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002659.29
LogP ≤ 526.10
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1042

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze N-[5-(anilinomethyl)-1-(3-methoxypropyl)benzimidazol-2-yl]-1,2-oxazole-5-carboxamide;4-cyano-N-[5-[[cyclohexyl(methyl)amino]methyl]-1-(3-imidazol-1-ylpropyl)benzimidazol-2-yl]benzamide;4-cyano-N-[5-[[cyclopentylmethyl(methyl)amino]methyl]-1-(3-methoxypropyl)benzimidazol-2-yl]benzamide;N-[5-[(cyclohexylamino)methyl]-1-(3-methoxypropyl)benzimidazol-2-yl]-1,2-oxazole-5-carboxamide;N-[5-[[cyclohexyl(methyl)amino]methyl]-1-(3-imidazol-1-ylpropyl)benzimidazol-2-yl]-1,2-oxazole-5-carboxamide;N-[5-[[cyclohexyl(methyl)amino]methyl]-1-(3-methoxypropyl)benzimidazol-2-yl]-1,2-oxazole-5-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[5-(anilinomethyl)-1-(3-methoxypropyl)benzimidazol-2-yl]-1,2-oxazole-5-carboxamide;4-cyano-N-[5-[[cyclohexyl(methyl)amino]methyl]-1-(3-imidazol-1-ylpropyl)benzimidazol-2-yl]benzamide;4-cyano-N-[5-[[cyclopentylmethyl(methyl)amino]methyl]-1-(3-methoxypropyl)benzimidazol-2-yl]benzamide;N-[5-[(cyclohexylamino)methyl]-1-(3-methoxypropyl)benzimidazol-2-yl]-1,2-oxazole-5-carboxamide;N-[5-[[cyclohexyl(methyl)amino]methyl]-1-(3-imidazol-1-ylpropyl)benzimidazol-2-yl]-1,2-oxazole-5-carboxamide;N-[5-[[cyclohexyl(methyl)amino]methyl]-1-(3-methoxypropyl)benzimidazol-2-yl]-1,2-oxazole-5-carboxamide?
The IUPAC name of N-[5-(anilinomethyl)-1-(3-methoxypropyl)benzimidazol-2-yl]-1,2-oxazole-5-carboxamide;4-cyano-N-[5-[[cyclohexyl(methyl)amino]methyl]-1-(3-imidazol-1-ylpropyl)benzimidazol-2-yl]benzamide;4-cyano-N-[5-[[cyclopentylmethyl(methyl)amino]methyl]-1-(3-methoxypropyl)benzimidazol-2-yl]benzamide;N-[5-[(cyclohexylamino)methyl]-1-(3-methoxypropyl)benzimidazol-2-yl]-1,2-oxazole-5-carboxamide;N-[5-[[cyclohexyl(methyl)amino]methyl]-1-(3-imidazol-1-ylpropyl)benzimidazol-2-yl]-1,2-oxazole-5-carboxamide;N-[5-[[cyclohexyl(methyl)amino]methyl]-1-(3-methoxypropyl)benzimidazol-2-yl]-1,2-oxazole-5-carboxamide (CID 158848842) is N-[5-(anilinomethyl)-1-(3-methoxypropyl)benzimidazol-2-yl]-1,2-oxazole-5-carboxamide;4-cyano-N-[5-[[cyclohexyl(methyl)amino]methyl]-1-(3-imidazol-1-ylpropyl)benzimidazol-2-yl]benzamide;4-cyano-N-[5-[[cyclopentylmethyl(methyl)amino]methyl]-1-(3-methoxypropyl)benzimidazol-2-yl]benzamide;N-[5-[(cyclohexylamino)methyl]-1-(3-methoxypropyl)benzimidazol-2-yl]-1,2-oxazole-5-carboxamide;N-[5-[[cyclohexyl(methyl)amino]methyl]-1-(3-imidazol-1-ylpropyl)benzimidazol-2-yl]-1,2-oxazole-5-carboxamide;N-[5-[[cyclohexyl(methyl)amino]methyl]-1-(3-methoxypropyl)benzimidazol-2-yl]-1,2-oxazole-5-carboxamide.
What is the SMILES notation for N-[5-(anilinomethyl)-1-(3-methoxypropyl)benzimidazol-2-yl]-1,2-oxazole-5-carboxamide;4-cyano-N-[5-[[cyclohexyl(methyl)amino]methyl]-1-(3-imidazol-1-ylpropyl)benzimidazol-2-yl]benzamide;4-cyano-N-[5-[[cyclopentylmethyl(methyl)amino]methyl]-1-(3-methoxypropyl)benzimidazol-2-yl]benzamide;N-[5-[(cyclohexylamino)methyl]-1-(3-methoxypropyl)benzimidazol-2-yl]-1,2-oxazole-5-carboxamide;N-[5-[[cyclohexyl(methyl)amino]methyl]-1-(3-imidazol-1-ylpropyl)benzimidazol-2-yl]-1,2-oxazole-5-carboxamide;N-[5-[[cyclohexyl(methyl)amino]methyl]-1-(3-methoxypropyl)benzimidazol-2-yl]-1,2-oxazole-5-carboxamide?
The canonical SMILES for N-[5-(anilinomethyl)-1-(3-methoxypropyl)benzimidazol-2-yl]-1,2-oxazole-5-carboxamide;4-cyano-N-[5-[[cyclohexyl(methyl)amino]methyl]-1-(3-imidazol-1-ylpropyl)benzimidazol-2-yl]benzamide;4-cyano-N-[5-[[cyclopentylmethyl(methyl)amino]methyl]-1-(3-methoxypropyl)benzimidazol-2-yl]benzamide;N-[5-[(cyclohexylamino)methyl]-1-(3-methoxypropyl)benzimidazol-2-yl]-1,2-oxazole-5-carboxamide;N-[5-[[cyclohexyl(methyl)amino]methyl]-1-(3-imidazol-1-ylpropyl)benzimidazol-2-yl]-1,2-oxazole-5-carboxamide;N-[5-[[cyclohexyl(methyl)amino]methyl]-1-(3-methoxypropyl)benzimidazol-2-yl]-1,2-oxazole-5-carboxamide is CN(Cc1ccc2c(c1)nc(NC(=O)c1ccc(C#N)cc1)n2CCCn1ccnc1)C1CCCCC1.CN(Cc1ccc2c(c1)nc(NC(=O)c1ccno1)n2CCCn1ccnc1)C1CCCCC1.COCCCn1c(NC(=O)c2ccc(C#N)cc2)nc2cc(CN(C)CC3CCCC3)ccc21.COCCCn1c(NC(=O)c2ccno2)nc2cc(CN(C)C3CCCCC3)ccc21.COCCCn1c(NC(=O)c2ccno2)nc2cc(CNC3CCCCC3)ccc21.COCCCn1c(NC(=O)c2ccno2)nc2cc(CNc3ccccc3)ccc21.
What is the InChIKey of N-[5-(anilinomethyl)-1-(3-methoxypropyl)benzimidazol-2-yl]-1,2-oxazole-5-carboxamide;4-cyano-N-[5-[[cyclohexyl(methyl)amino]methyl]-1-(3-imidazol-1-ylpropyl)benzimidazol-2-yl]benzamide;4-cyano-N-[5-[[cyclopentylmethyl(methyl)amino]methyl]-1-(3-methoxypropyl)benzimidazol-2-yl]benzamide;N-[5-[(cyclohexylamino)methyl]-1-(3-methoxypropyl)benzimidazol-2-yl]-1,2-oxazole-5-carboxamide;N-[5-[[cyclohexyl(methyl)amino]methyl]-1-(3-imidazol-1-ylpropyl)benzimidazol-2-yl]-1,2-oxazole-5-carboxamide;N-[5-[[cyclohexyl(methyl)amino]methyl]-1-(3-methoxypropyl)benzimidazol-2-yl]-1,2-oxazole-5-carboxamide?
The InChIKey is IZEKAXPSXPAAIT-UHFFFAOYSA-N. The full InChI is InChI=1S/C29H33N7O.C27H33N5O2.C25H31N7O2.C23H31N5O3.C22H29N5O3.C22H23N5O3/c1-34(25-6-3-2-4-7-25)20-23-10-13-27-26(18-23)32-29(36(27)16-5-15-35-17-14-31-21-35)33-28(37)24-11-8-22(19-30)9-12-24;1-31(18-21-6-3-4-7-21)19-22-10-13-25-24(16-22)29-27(32(25)14-5-15-34-2)30-26(33)23-11-8-20(17-28)9-12-23;1-30(20-6-3-2-4-7-20)17-19-8-9-22-21(16-19)28-25(29-24(33)23-10-11-27-34-23)32(22)14-5-13-31-15-12-26-18-31;1-27(18-7-4-3-5-8-18)16-17-9-10-20-19(15-17)25-23(28(20)13-6-14-30-2)26-22(29)21-11-12-24-31-21;2*1-29-13-5-12-27-19-9-8-16(15-23-17-6-3-2-4-7-17)14-18(19)25-22(27)26-21(28)20-10-11-24-30-20/h8-14,17-18,21,25H,2-7,15-16,20H2,1H3,(H,32,33,37);8-13,16,21H,3-7,14-15,18-19H2,1-2H3,(H,29,30,33);8-12,15-16,18,20H,2-7,13-14,17H2,1H3,(H,28,29,33);9-12,15,18H,3-8,13-14,16H2,1-2H3,(H,25,26,29);8-11,14,17,23H,2-7,12-13,15H2,1H3,(H,25,26,28);2-4,6-11,14,23H,5,12-13,15H2,1H3,(H,25,26,28).
What are the key properties of N-[5-(anilinomethyl)-1-(3-methoxypropyl)benzimidazol-2-yl]-1,2-oxazole-5-carboxamide;4-cyano-N-[5-[[cyclohexyl(methyl)amino]methyl]-1-(3-imidazol-1-ylpropyl)benzimidazol-2-yl]benzamide;4-cyano-N-[5-[[cyclopentylmethyl(methyl)amino]methyl]-1-(3-methoxypropyl)benzimidazol-2-yl]benzamide;N-[5-[(cyclohexylamino)methyl]-1-(3-methoxypropyl)benzimidazol-2-yl]-1,2-oxazole-5-carboxamide;N-[5-[[cyclohexyl(methyl)amino]methyl]-1-(3-imidazol-1-ylpropyl)benzimidazol-2-yl]-1,2-oxazole-5-carboxamide;N-[5-[[cyclohexyl(methyl)amino]methyl]-1-(3-methoxypropyl)benzimidazol-2-yl]-1,2-oxazole-5-carboxamide?
N-[5-(anilinomethyl)-1-(3-methoxypropyl)benzimidazol-2-yl]-1,2-oxazole-5-carboxamide;4-cyano-N-[5-[[cyclohexyl(methyl)amino]methyl]-1-(3-imidazol-1-ylpropyl)benzimidazol-2-yl]benzamide;4-cyano-N-[5-[[cyclopentylmethyl(methyl)amino]methyl]-1-(3-methoxypropyl)benzimidazol-2-yl]benzamide;N-[5-[(cyclohexylamino)methyl]-1-(3-methoxypropyl)benzimidazol-2-yl]-1,2-oxazole-5-carboxamide;N-[5-[[cyclohexyl(methyl)amino]methyl]-1-(3-imidazol-1-ylpropyl)benzimidazol-2-yl]-1,2-oxazole-5-carboxamide;N-[5-[[cyclohexyl(methyl)amino]methyl]-1-(3-methoxypropyl)benzimidazol-2-yl]-1,2-oxazole-5-carboxamide has a molecular weight of 2659.29 g/mol, XLogP of 26.10, 55 rotatable bonds, 8 hydrogen bond donors, and 42 hydrogen bond acceptors.
Where does this data come from?
All data for N-[5-(anilinomethyl)-1-(3-methoxypropyl)benzimidazol-2-yl]-1,2-oxazole-5-carboxamide;4-cyano-N-[5-[[cyclohexyl(methyl)amino]methyl]-1-(3-imidazol-1-ylpropyl)benzimidazol-2-yl]benzamide;4-cyano-N-[5-[[cyclopentylmethyl(methyl)amino]methyl]-1-(3-methoxypropyl)benzimidazol-2-yl]benzamide;N-[5-[(cyclohexylamino)methyl]-1-(3-methoxypropyl)benzimidazol-2-yl]-1,2-oxazole-5-carboxamide;N-[5-[[cyclohexyl(methyl)amino]methyl]-1-(3-imidazol-1-ylpropyl)benzimidazol-2-yl]-1,2-oxazole-5-carboxamide;N-[5-[[cyclohexyl(methyl)amino]methyl]-1-(3-methoxypropyl)benzimidazol-2-yl]-1,2-oxazole-5-carboxamide is sourced from PubChem (CID 158848842), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).